DoH Partners with GEMMABio to Enhance Gene Therapies for Spinal Muscular Atrophy Type 1
Abu dhabi: The Department of Health – Abu Dhabi (DoH), M42, PureHealth, and GEMMABio Therapeutics have announced a strategic partnership to advance gene therapies for children with Spinal Muscular Atrophy Type 1 (SMA1). This collaboration aims to deve…